Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Asthma may increase the risk of alopecia areata.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Th22 cells are essential for Tβ15-induced hair growth in mice.

A group has developed therapies that show promise for treating cancer and various other conditions.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Dupilumab may cause hair loss, so patients should be monitored.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Dupilumab helps children with alopecia areata regrow hair safely.

Upadacitinib improved multiple immune-related conditions in one patient.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Increased PPARGC1α relates to hair thinning in common baldness.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.